Higher expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus provides rationale for monitoring these subgroups for high infectivity and poor COVID-19 outcomes. This evidence concerns the gene TMPRSS2 and COVID-19.